Effects of losartan on hypertension and left ventricular mass: a long-term study

Autor: Diana Iarussi, Domenico Galzerano, Giuseppe Limongelli, Aldo Iacono, M A Tedesco, G. Di Salvo, D Aquino, Gennaro Ratti, S. Mennella
Přispěvatelé: Tedesco, Ma, Ratti, G, Aquino, D, Caccavale, A, Limongelli, Giuseppe, DI SALVO, Giovanni
Rok vydání: 1998
Předmět:
Zdroj: Scopus-Elsevier
ISSN: 1476-5527
0950-9240
DOI: 10.1038/sj.jhh.1000685
Popis: This study evaluated the anti-hypertensive efficacy, tolerability and effects on left ventricular mass of losartan, a selective angiotensin II receptor antagonist, after 22 months in patients with essential hypertension. The study included 77 hypertensive patients who were randomised at baseline to 22 months double-blind once-daily treatment with losartan 50 mg (L group n = 44 patients, mean age 54+/-9 years) or hydrochlorothiazide 25 mg (HCTZ group, n = 33 patients, mean age 56+/-7 years). Routine haematology, blood chemistry, standard electrocardiography, echocardiography and ambulatory non-invasive 24-h blood pressure (BP) monitoring were performed at baseline and after 10 and 22 months. The results showed good tolerability and a significant mean systolic and diastolic BP reduction in all groups (L group: 22 mm Hg and 11 mm Hg; HCTZ group: 11 mm Hg and 7 mm Hg, respectively for systolic and diastolic mean BP). Moreover, a remarkable reduction in left ventricular mass index was reached after 10 and 22 months only in the L group (L group: delta = -11 g/m2, P
Databáze: OpenAIRE